Roivant Sciences Ltd
ROIV · NASDAQ
Roivant develops transformative medicines faster by building technologies and developing talent in creative ways, leveraging the Roivant platform to launch "Vants" - nimble and focused biopharmaceutical and health technology companies
Market Data
Price
$29.70
+0.17 (+0.58%)
Market Cap$21.13B
P/E Ratio—
EPS$—
52W High$30.03
52W Low$8.73
Beta1.23
Data from Finnhub · Updated Mar 11, 2026